NEW YORK, Aug. 8, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neogen Corporation (NASDAQ: NEOG) between January 5, 2023 and June 3, 2025 (the "Class Period"), of the important September 16, 2025 lead plaintiff deadline. So...
Related Questions
How might the lead plaintiff deadline affect the composition of the plaintiff group and potential settlement distribution?
What are the chances that the class-action suit will affect the company's credit facilities or covenants?
Are there any precedents with similar biotech/food safety companies that faced securities fraud claims?
Could the lawsuit trigger a short‑selling wave or increased volatility in the stock price?
What is the probability that NEOG will be named as a defendant in additional related suits?
How might this lawsuit influence institutional and retail investor sentiment toward NEOG?
Could this lawsuit affect any pending acquisitions, partnerships, or R&D collaborations for NEOG?
What potential financial impact could a settlement or judgment have on NEOG's balance sheet and cash flow?
How likely is it that the securities fraud lawsuit will result in a significant settlement or judgment?
Will the legal expenses and potential settlement affect the company's upcoming earnings guidance?